US food and drug administration (FDA) has released more than £ 64,000 butter, which quoted concerns about allergens with non -reported milk that could cause adverse health effects in consumers.
According to a warning of 14 July, Bunge North America, a grocery -based company based in Chesterfield, Missouri, voluntarily reminded 1,800 cases of its mixture of the European style of butter. The affected butter was distributed to 12 centers in the United States and one in the Dominican Republic.
FDA resembles more than £ 64,000 butter due to the risk of milk allergen
31. July FDA classified withdrawal according to its risk category II-Druhou the highest warning level of the agency-it was that “consumption could represent a temporary or medically reversible adverse health consequences”.
This problem is to indicate a product that failed to declare the presence of milk, a known allergen that can cause reactions in sensitive individuals. No injuries or illnesses have been reported in connection with the dismissal.
The USA Today addressed Bunge North America to express the procedures of supervision and appeal, but has not yet received an answer.
Bunge North America is the main player in the field of agriculture and sector of food components, produces and distributes objects such as corn, wheat, rice, soybeans and feed, along with cooking ingredients such as butter mixtures.
Consumers who may have purchased the affected product are advised to check the European NH mixture of European style and stop using immediately if any unnounced risks of allergens are used. The FDA urges the consumer of milk allergy or sensitivity to caution and carefully monitors product withdrawal alerts.
(Tagstotranslate) FDA resembles more than 64
